SynthesisPloS one2024

Combinatorial treatment with traditional medicinal preparations and VEGFR-tyrosine kinase inhibitors for middle-advanced primary liver cancer: A systematic review and meta-analysis.

Hui-Bo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.